Outcome measures for physical fatigue in individuals with multiple sclerosis: a systematic review

References

• Occupational therapy and neurological conditions. 2016.
   Google Scholar
• Fisk JD, Pontefract A, Ritvo PG, et al. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci /J Can Des Sci Neurol. 1994;21(1). DOI:10.1017/S0317167100048691
   Google Scholar
• Dyck I, Jongbloed L. “Women with multiple sclerosis and employment issues: A focus on social and institutional environments,”. Can J Occup Ther. 2000;67(5). DOI:10.1177/000841740006700506
   PubMedGoogle Scholar
• Schwid SR, Covington M, Segal BM, et al. Fatigue in multiple sclerosis: current understanding and future directions. J Rehabil Res Dev. 2002;39(2):211-24.
   PubMedGoogle Scholar
• Amatya B, Khan F, Galea M. “Rehabilitation for people with multiple sclerosis: an overview of Cochrane reviews,”. Cochrane Database Syst Rev. 2019. DOI:10.1002/14651858.CD012732.pub2
   PubMed Web of Science ®Google Scholar
• Krupp LB. The fatigue severity scale. Arch. Neurol. 1989;46(10):1121-1123.
   PubMedGoogle Scholar
• M. S. C. for C. P. Guidelines. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Washington D.C:Paralyzed Veterans Am. 1998.
   Google Scholar
• Galeoto G, Scialpi A, Grassi ML, et al. “General sleep disturbance scale: translation, cultural adaptation, and psychometric properties of the Italian version,”. Cranio - J Craniomandib Pract. 2019:1-9. DOI: 10.1080/08869634.2019.1627067.
   Google Scholar
• Savona A, Ferralis L, Saffioti M, et al. Evaluation of intra- and inter-rater reliability and concurrent validity of the italian version of the jebsen–Taylor hand function test in adults with rheumatoid arthritis. Hand Therapy. 2019;24(2):48-54. DOI:10.1177/1758998319843554.
   Web of Science ®Google Scholar
• Galeoto G, Iori F, De Santis R, et al. “The outcome measures for loss of functionality in the activities of daily living of adults after stroke: a systematic review,”. Topic Stroke Rehabilitat. 2019;26(3):236-245. DOI:10.1080/10749357.2019.1574060.
   PubMed Web of Science ®Google Scholar
• Romagnoli G, Leone A, Romagnoli G, et al. Occupational Therapy’s efficacy in children with asperger’s syndrome: a systematic review of randomized controlled trials. Clin Ter. 2019;170(5):e382-e387. DOI: 10.7417/CT.2019.2164.
   PubMed Web of Science ®Google Scholar
• Berardi A, Galeoto G, Lucibello L, et al. Athletes with disability’ satisfaction with sport wheelchairs: an Italian cross sectional study. Disabil Rehabil Assist Technol. 2020. DOI:10.1080/17483107.2020.1800114
   Web of Science ®Google Scholar
• Miniera F, Berardi A, Panuccio F, et al. Measuring environmental barriers: validation and cultural adaptation of the Italian version of the Craig hospital inventory of environmental factors (CHIEF) scale. Occup Ther Heal Care. 2020;34(4). DOI:10.1080/07380577.2020.1834174
   PubMed Web of Science ®Google Scholar
• Panuccio F, Galeoto G, Marquez MA, et al. General sleep disturbance scale (GSDS-IT) in people with spinal cord injury: a psychometric study. Spinal Cord. 2020;58(11):1183-1188. DOI:10.1038/s41393-020-0500-0.
   PubMed Web of Science ®Google Scholar
• Panuccio F, Berardi A, Marquez MA, et al. “Development of the pregnancy and motherhood evaluation questionnaire (PMEQ) for evaluating and measuring the impact of physical disability on pregnancy and the management of motherhood: a pilot study,”. Disabil Rehabil Aug. 2020:1–7. DOI:10.1080/09638288.2020.1802520
   PubMed Web of Science ®Google Scholar
• Berardi A, Regoli E, Tofani M, et al. “Tools to assess the quality of life in patients with parkinson’s disease: a systematic review,”. Expert Rev Pharmacoecon Outcomes Res. 2020;21(1):55-68. DOI:10.1080/14737167.2021.1841638
   PubMed Web of Science ®Google Scholar
• Chandler J, Churchill R, Lasserson T, et al. Methodological standards for the conduct of new Cochrane intervention reviews. 2013. Available from:http://editorial-unit.cochrane.org/sites/editorial-unit.cochrane.org/files/uploads/MECIR_conduct_standards%202.3%2002122013.pdf.
   Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2021;6(7):e1000100. DOI:10.1371/journal.pmed.1000100.
   Web of Science ®Google Scholar
• Ruggieri M, Palmisano, B., Fratocchi G, et al. “Validated fall risk assessment tools for use with older adults: A systematic review,”. Phys Occup Ther Geriatr. Oct. 2018;36(4):331–353.
   Web of Science ®Google Scholar
• Noyes J, Lewin S. Chapter 5: extracting qualitative evidence. Suppl Guid Incl Qual Res Cochrane Syst Rev Interv. 2011.
   Google Scholar
• Bates S, Coren E. “Systematic map no.1: the extent and impact of parental mental health problems on families and the acceptability, accessibility and effectiveness of interventions.,”. London SCIE. 2006.
   Google Scholar
• Mokkink LB, Terwee CB, Patrick DL, et al. “The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes,”. J Clin Epidemiol. 2010;63(7):737-745. DOI:10.1016/j.jclinepi.2010.02.006.
   Web of Science ®Google Scholar
• Mokkink LB, Terwee CB, Patrick DL. COSMIN checklist manual. COSMIN. 2012.
   Google Scholar
• Nunnally JC, Psychometric Theory (1979).
   Google Scholar
• Ford H, Trigwell P, Johnson M. The nature of fatigue in multiple sclerosis. J. Psychosom. Res. 1998;45(1). DOI:10.1016/S0022-3999(98)00004-X
   PubMed Web of Science ®Google Scholar
• Huh SY, Joo J, Kim SH, et al. Validity of Korean versions of the multiple sclerosis impact scale and the multiple sclerosis international quality of life questionnaire. J. Clin. Neurol. 2014;10(2):148-56. DOI:10.3988/jcn.2014.10.2.148.
   Web of Science ®Google Scholar
• Gompertz P, Pound P, Ebrahim S. Validity of the extended activities of daily living scale. Clin. Rehabil. 1994;8(4). DOI:10.1177/026921559400800401
   Google Scholar
• Lopes J, Lavado EL, Kallaur AP, et al. Assessment of fatigue in multiple sclerosis: methodological quality of adapted original versions available in Brazil of self-report instruments. Fisioter E Pesqui. 2014;21(4):392-397.
   Google Scholar
• Mills RJ, Young CA, Nicholas RS, et al. Rasch analysis of the Fatigue Severity Scale in multiple sclerosis. Mult Scler. 2009;15(1). DOI:10.1177/1352458508096215
   PubMed Web of Science ®Google Scholar
• Salehpoor G, Rezaei S, Hosseininezhad M. Psychometric properties of fatigue severity scale in patients with multiple sclerosis. J Kerman Univ Med Sci. 2013.
   Google Scholar
• Hernandez-Ronquillo L, Moien-Afshari F, Knox K, et al. How to measure fatigue in epilepsy? The validation of three scales for clinical use. Epilepsy Research. 2011;95(1–2). DOI:10.1016/j.eplepsyres.2011.03.010
   PubMed Web of Science ®Google Scholar
• Johansson S, Kottorp A, Lee KA, et al. “Can the fatigue severity scale 7-item version be used across different patient populations as a generic fatigue measure - a comparative study using a Rasch model approach,”. Health Qual Life Outcomes. 2014;vol.12no.(1):pp.1–9.
   PubMed Web of Science ®Google Scholar
• Benito-León J, Martínez-Martín P, Frades B, et al. Impact of fatigue in multiple sclerosis: the fatigue impact scale for daily use (D-FIS). Mult Scler. 2007;13(5)):645-51. DOI:10.1177/1352458506073528.
   PubMed Web of Science ®Google Scholar
• Ghajarzadeh M, Jalilian R, Eskandari G, et al. Validity and reliability of Persian version of modified fatigue impact scale (MFIS) questionnaire in Iranian patients with multiple sclerosis. Disabil Rehabil. 2013;35(18). DOI:10.3109/09638288.2012.742575
   PubMed Web of Science ®Google Scholar
• Harirchian MH, Nasergivechi S, Maddah M, et al. Evaluation of the Persian version of modified fatigue impact scale in Iranian patients with multiple sclerosis. Iran J Neurol. 2013;12(1):32-4.
   Google Scholar
• Khalil H, Al-Shorman A, Alghwiri AA, et al. Cross cultural adaptation and psychometric evaluation of an Arabic version of the modified fatigue impact scale in people with multiple sclerosis. Mult. Scler. Relat. Disord. 2020;39:101878. DOI: 10.1016/j.msard.2019.101878.
   Web of Science ®Google Scholar
• Meca-Lallana V, Brañas-Pampillón M, Higueras Y, et al. Assessing fatigue in multiple sclerosis: psychometric properties of the five-item modified fatigue impact scale (MFIS-5). Mult Scler J - Exp Transl Clin. 2019;5(4):2055217319887987. DOI: 10.1177/2055217319887987.
   Google Scholar
• Mills RJ, Calabresi M, Tennant A, et al. Perceived changes and minimum clinically important difference of the neurological fatigue index for multiple sclerosis (NFI-MS). Mult. Scler. J. 2013;19(4). DOI:10.1177/1352458512457840
   PubMed Web of Science ®Google Scholar
• Motaharinezhad F, Parvaneh, S., Ghahari, S, et al. Validation of Persian version of comprehensive fatigue assessment battery for multiple sclerosis (CFAB-MS). J Maz Univ Med Sci. 2015:56-66.
   Google Scholar
• Chilcot J, Norton S, Kelly ME, et al. The chalder fatigue questionnaire is a valid and reliable measure of perceived fatigue severity in multiple sclerosis. Mult. Scler. 2016;22(5). DOI:10.1177/1352458515598019
   PubMed Web of Science ®Google Scholar
• Jason LA, Ropacki MT, Santoro NB, et al. A screening instrument for chronic fatigue syndrome: reliability and validity. J. Chronic Fatigue Syndr. 1997;3(1):39-59. DOI:10.1300/J092v03n01_04.
   Google Scholar
• Worm-Smeitink M, Gielissen M, Bloot L, et al. The assessment of fatigue: psychometric qualities and norms for the checklist individual strength. J. Psychosom. Res. 2017;98:40–46.DOI: 10.1016/j.jpsychores.2017.05.007.
   PubMed Web of Science ®Google Scholar
• Kos D, et al. Electronic visual analogue scales for pain, fatigue, anxiety and quality of life in people with multiple sclerosis using smartphone and tablet: A reliability and feasibility study. Clin Rehabil. 2017;31(9). DOI:10.1177/0269215517692641.
   PubMed Web of Science ®Google Scholar
• Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: A new instrument. J Psychosom Res. 1993;37(7). DOI:10.1016/0022-3999(93)90104-N
   PubMed Web of Science ®Google Scholar
• Iriarte J, Katsamakis G, De Castro P. The fatigue descriptive scale (FDS): A useful tool to evaluate fatigue in multiple sclerosis. Mult. Scler. 1999;5(1). DOI:10.1177/135245859900500103
   PubMed Web of Science ®Google Scholar
• Iriarte J, Castro P. “Correlation between symptom fatigue and muscular fatigue in multiple sclerosis,”. Eur J Neurol. Nov. 1998;vol.5no.(6):pp.579–585.
   PubMed Web of Science ®Google Scholar
• Hudgens S, Schüler R, Stokes J, et al. Development and validation of the FSIQ-RMS: A new patient-reported questionnaire to assess symptoms and impacts of fatigue in relapsing multiple sclerosis. Value Heal. 2019;22(4). DOI:10.1016/j.jval.2018.11.007
   PubMed Web of Science ®Google Scholar
• Behrangrad S, Kordi Yoosefinejad A. Validity and reliability of the multidimensional assessment of fatigue scale in Iranian patients with relapsing-remitting subtype of multiple sclerosis. Disabil Rehabil. 2018;40(6). DOI:10.1080/09638288.2016.1271024
   PubMed Web of Science ®Google Scholar
• Thomas S, Kersten P, Thomas PW. The multiple sclerosis-fatigue self-efficacy (MS-FSE) scale: initial validation. Clin Rehabil. 2015;29(4):376-87. DOI: 10.1177/0269215514543702.
   Web of Science ®Google Scholar
• Carlozzi NE, Boileau NR, Murphy SL, et al., Validation of the Pittsburgh fatigability scale in a mixed sample of adults with and without chronic conditions, J. Health Psychol. 2019:1359105319877448. DOI:10.1177/1359105319877448
   Google Scholar
• Cook KF, Bamer AM, Roddey TS, et al. A PROMIS fatigue short form for use by individuals who have multiple sclerosis. Qual. Life Res. 2012;21(6). DOI:10.1007/s11136-011-0011-8
   Web of Science ®Google Scholar
• Johansson S, Ytterberg C, Back B, et al. The Swedish Occupational Fatigue Inventory in people with multiple sclerosis. J. Rehabil. Med. 2008;40(9). DOI:10.2340/16501977-0236
   PubMed Web of Science ®Google Scholar
• Flachenecker P, Müller G, König H, et al. [“Fatigue” in multiple sclerosis. Development and validation of the ‘würzburger fatigue inventory for MS’]. Nervenarzt. 2006;77(2):165-166. DOI: 10.1007/s00115-005-1990-x.
   PubMed Web of Science ®Google Scholar
• Flachenecker P, König H, Meer H, et al. Fatigue bei multiper sklerose: validierung des würzburger erschöpfungs-inventars bei multipler sklerose (WEIMUS). Neurol Und Rehabil. 2008;67:165-174.
   Google Scholar
• F. P., K. H., M. H., M. G., and R. P. “Fatigue in multiple sclerosis: validation of the weimus scale (‘wurzburger erschopfungs-inventar bei multipler sklerose’),”. Neurologie Und Rehabilitation. 2008;67:165-174.
   Google Scholar
• Chua AS, Glanz BI, Guarino AJ, et al. Patient-reported outcomes in multiple sclerosis: relationships among existing scales and the development of a brief measure. Mult. Scler. Relat. Disord. 2015;4(6):598-606. DOI:10.1016/j.msard.2015.09.004.
   PubMed Web of Science ®Google Scholar
• Cella DF, Dineen K, Arnason B, et al. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology. 1996;47(1):129-39. DOI:10.1212/WNL.47.1.129.
   PubMed Web of Science ®Google Scholar
• Chang CH, Cella D, Fernández O, et al. Quality of life in multiple sclerosis patients in Spain. Mult. Scler. 2002;8(6):527-31. DOI:10.1191/1352458502ms851oa.
   PubMed Web of Science ®Google Scholar
• Mendes MF, Balsimelli S, Stangehaus G, et al. Validation of the functional assessment of multiple sclerosis quality of life instrument in a Portuguese language. Arq Neuropsiquiatr. 2004;62(1):108-13. DOi: 10.1590/s0004-282x2004000100019.
   Web of Science ®Google Scholar
• Patti F, Russo P, Pappalardo A, et al. Predictors of quality of life among patients with multiple sclerosis: an italian cross-sectional study. J Neurol Sci. 2007;252(2). DOI:10.1016/j.jns.2006.10.017
   PubMed Web of Science ®Google Scholar
• Sørensen J, Bay J, Damsgaard T, et al. Validation of the Danish version of functional assessment of multiple sclerosis: A quality of life instrument. Mult. Scler. Int. 2011;2011:121530. DOI: 10.1155/2011/121530.
   PubMedGoogle Scholar
• Ensari I, Motl RW, McAuley E. Structural and construct validity of the Leeds multiple sclerosis quality of life scale. Qual. Life Res. 2016;25(6). DOI:10.1007/s11136-015-1202-5
   PubMed Web of Science ®Google Scholar
• Ford HL, Gerry E, Tennant A, et al. Developing a disease-specific quality of life measure for people with multiple sclerosis. Clin Rehabil. 2001;15(3). DOI:10.1191/026921501673658108
   PubMed Web of Science ®Google Scholar
• Akbiyik DI, Sumbuloglu V, Guney Z, et al. The validity and test-retest reliability of the Leeds multiple sclerosis quality of life scale in Turkish patients. Int. J. Rehabil. Res. 2009;32(2):162-166. DOI:10.1097/MRR.0b013e328329820f.
   PubMed Web of Science ®Google Scholar
• Greenhalgh J. An assessment of the feasibility and utility of the MS symptom and impact diary (MSSID). Qual. Life Res. 2005;14(5). DOI:10.1007/s11136-004-5389-0
   PubMed Web of Science ®Google Scholar
• Greenhalgh J, Ford H, Long AF, et al. The MS symptom and impact diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2004;75(4). DOI:10.1136/jnnp.2003.020529
   PubMed Web of Science ®Google Scholar
• Solari A, Filippini G, Mendozzi L, et al. Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry. 1999;67(2):158-62. DOI:10.1136/jnnp.67.2.158.
   PubMed Web of Science ®Google Scholar
• Miller A, Dishon S. Health-related quality of life in multiple sclerosis: psychometric analysis of inventories. Mult. Scler. 2005;11(4). DOI:10.1191/1352458505ms1169oa
   Web of Science ®Google Scholar
• Idiman E, Uzunel F, Ozakbas S et al. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample. J Neurol Sci. 2006;240(1–2):77-80. DOI: 10.1016/j.jns.2005.09.009
   Google Scholar
• Heiskanen S, Meriläinen P, Pietilä AM. “Health-related quality of life - testing the reliability of the MSQOL-54 instrument among MS patients,”. Scand J Caring Sci. 2007;21(2). DOI:10.1111/j.1471-6712.2007.00456.x
   PubMed Web of Science ®Google Scholar
• Pekmezovic T, Kisic Tepavcevic D, Kostic J, et al. Validation and cross-cultural adaptation of the disease-specific questionnaire MSQOL-54 in Serbian multiple sclerosis patients sample. Qual. Life Res. 2007;16(8). DOI:10.1007/s11136-007-9234-0
   PubMed Web of Science ®Google Scholar
• Füvesi J, Bencsik K, Benedek K, et al. Cross-cultural adaptation and validation of the ‘multiple sclerosis quality of life instrument’ in hungarian. Mult. Scler. 2008;14(3)):391-8. DOI:10.1177/1352458507082724.
   PubMed Web of Science ®Google Scholar
• El Alaoui Taoussi K, Ait Ben Haddou, Benomar A, et al.Quality of life and multiple sclerosis: Arabic language translation and transcultural adaptation of ‘mSQOL-54,. Rev Neurol (Paris). 2012;168(5):444–9. DOI: 10.1016/j.neurol.2011.10.011
   Google Scholar
• Catic T, Culig J, Suljic E, et al. Validation of the disease-specific questionnaire msqol-54 in Bosnia and Herzegovina multiple sclerosis patients sample. Med Arch (Sarajevo, Bosnia Herzegovina). 2017;71(2):103-106. DOI: 10.5455/medarh.2017.71.103-106.
   Google Scholar
• Estiasari R, Melani S, Kusumawardhani A, et al. Validation of the Indonesian version of multiple sclerosis quality of life-54 (MSQOL-54 INA) questionnaire. Health Qual Life Outcomes. 2019;17(1):120. DOI:10.1186/s12955-019-1190-1.
   PubMed Web of Science ®Google Scholar
• Stern B, Hojs Fabjan T, Rener-Sitar K, et al. Validation of the slovenian version of multiple sclerosis quality of life (MSQOL-54) instrument. Zdr Varst. 2017;56(4):260-267. DOI: 10.1515/sjph-2017-0035.
   PubMed Web of Science ®Google Scholar
• Ghaem H, Haghighi A, Jafari P, et al. Validity and reliability of the Persian version of the multiple sclerosis quality of life questionnaire. Neurol India. 2007;55(4). DOI:10.4103/0028-3886.33316
   PubMed Web of Science ®Google Scholar
• Rosato R, Testa S, Bertolotto A, et al. Development of a short version of MSQOL-54 using factor analysis and item response theory. PLoS One. 2016;11(4):e0153466. DOI:10.1371/journal.pone.0153466.
   Web of Science ®Google Scholar
• Baker G, Nair KPS, Baster K, et al. Reliability and acceptability of the multiple sclerosis quality of life-29 questionnaire in an English-speaking cohort. Mult. Scler. J. 2019;25(11). DOI:10.1177/1352458518776583
   Web of Science ®Google Scholar
• Rosato R, Testa S, Bertolotto A, et al. “eMSQOL-29: prospective validation of the abbreviated, electronic version of MSQOL-54,”. Mult Scler J. 2019;25(6):856-866. DOI:10.1177/1352458518774935.
   Web of Science ®Google Scholar
• Triantafyllou N, Triantafillou A, Tsivgoulis G. Validity and reliability of the Greek version of the multiple sclerosis international quality-of-life questionnaire. J Clin Neurol. 2009;5(4). DOI:10.3988/jcn.2009.5.4.173
   PubMed Web of Science ®Google Scholar
• Beiske AG, Baumstarck K, Nilsen RM, et al. Validation of the multiple sclerosis international quality of life (MusiQoL) questionnaire in Norwegian patients. Acta Neurol. Scand. 2012;125(3). DOI:10.1111/j.1600-0404.2011.01518.x
   PubMed Web of Science ®Google Scholar
• Michel P, Baumstarck K, Ghattas B, et al. A multidimensional computerized adaptive short-form quality of life questionnaire developed and validated for multiple sclerosis. Med (United States). 2016;95(14):e3068. DOI: 10.1097/MD.0000000000003068.
   Google Scholar
• Correia H, Pérez B, Arnold B, et al. Spanish translation and linguistic validation of the quality of life in neurological disorders (Neuro-QoL) measurement system. Qual Life Res. 2015;24(3):753-756. DOI:10.1007/s11136-014-0786-5.
   Web of Science ®Google Scholar
• Miller DM, Bethoux F, Victorson D, et al. Validating neuro-QoL short forms and targeted scales with people who have multiple sclerosis. Mult Scler. 2016;22(6):830-41. DOI: 10.1177/1352458515599450.
   Web of Science ®Google Scholar
• Medina LD, Torres S, Alvarez E, et al. Patient-reported outcomes in multiple sclerosis: validation of the quality of life in neurological disorders (Neuro-QoLTM) short forms. Mult Scler J - Exp Transl Clin. 2019;5(4):2055217319885986. DOI: 10.1177/2055217319885986.
   Google Scholar
• Marrie RA, Goldman M. , “Validity of performance scales for disability assessment in multiple sclerosis. Mult. Scler. 2007;13(9). DOI:10.1177/1352458507078388
   Web of Science ®Google Scholar
• Chamot E, Kister I, Cutter GR. Item response theory-based measure of global disability in multiple sclerosis derived from the performance scales and related items. BMC Neurology. 2014;14(1). DOI:10.1186/s12883-014-0192-1
   PubMed Web of Science ®Google Scholar
• Schwartz CE, Bode RK, Quaranto R, et al. The symptom inventory disability-specific short forms for multiple sclerosis: reliability and factor structure. Arch Phys Med Rehabil. 2012;93(9):1629-1636.e2. DOI: 10.1016/j.apmr.2012.03.006.
   Web of Science ®Google Scholar
• Green R, Kalina J, Ford R, et al. SymptoMScreen: A tool for rapid assessment of symptom severity in ms across multiple domains. Appl Neuropsychol. 2017;24(2). DOI:10.1080/23279095.2015.1125905
   Web of Science ®Google Scholar
• Fitzgerald KC, Salter A, Tyry T, et al. Validation of the symptoMScreen with performance-based or clinician-assessed outcomes. Mult Scler Relat Disord. 2019;29:86-93. DOI: 10.1016/j.msard.2019.01.031
   Google Scholar
• Yamada S,  Liu M, Hase K, et al. Development of a short version of the motor fimTM for use in long-term care settings. J Rehabil Med. 2006;38(1):50-56. DOI:10.1080/16501970510044034.
   PubMed Web of Science ®Google Scholar
• Matza LS, Stewart KD, Phillips G, et al. Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: the clinician rating of multiple sclerosis (CRoMS). Mult. Scler. Relat. Disord. 2019;35. DOI:10.1016/j.msard.2019.06.024
   PubMed Web of Science ®Google Scholar
• Marrie RA, Cutter G, Tyry T, et al. Validation of the NARCOMS registry: fatigue assessment. Mult Scler. 2005;11(5):583-4. DOI: 10.1191/1352458505ms1216oa.
   Web of Science ®Google Scholar
• Drummond AE, Parker CJ, Gladman JR, et al. Development and validation of the Nottingham leisure questionnaire (NLQ). Clin Rehabil. 2001;15(6):647–56. DOI: 10.1191/0269215501cr438oa
   Google Scholar
• Al-Sobayel HI, Al-Hugail HA, AlSaif RM, et al. Validation of an Arabic version of fatigue severity scale. Saudi Med. J. 2016;37(1):73-78. DOI:10.15537/smj.2016.1.13055.
   PubMed Web of Science ®Google Scholar
• Gershon RC, Lai JS, Bode R, et al. Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. Qual Life Res. 2012;21(3)475-486. DOI:10.1007/s11136-011-9958-8.
   PubMed Web of Science ®Google Scholar
• Krupp LB, Larocca NG, Muir Nash J, et al. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch. Neurol. 1989;46(10). DOI:10.1001/archneur.1989.00520460115022
   PubMedGoogle Scholar
• Valko PO, Bassetti CL, Bloch KE, et al. Validation of the fatigue severity scale in a Swiss cohort. Sleep. 2008;31. DOI:10.1093/sleep/31.11.1601
   PubMed Web of Science ®Google Scholar
• Reske D, Pukrop R, Scheinig K, et al. Measuring fatigue in patients with multiple sclerosis with standardized methods in German speaking areas. Fortschritte Der Neurol Psychiatr. 2006;74(9):497-502. DOI: 10.1055/s-2006-932189.
   PubMed Web of Science ®Google Scholar
• Armutlu K, Korkmaz NC, Keser I, et al. The validity and reliability of the fatigue severity scale in Turkish multiple sclerosis patients. Int. J. Rehabil. Res. 2007;30(1):81–85. DOI:10.1097/MRR.0b013e3280146ec4.
   PubMed Web of Science ®Google Scholar
• Ottonello M, Pellicciari L, Giordano A, et al. Rasch analysis of the fatigue severity scale in italian subjects with multiple sclerosis. J. Rehabil. Med. 2016;48(7). DOI:10.2340/16501977-2116
   PubMed Web of Science ®Google Scholar
• Learmonth YC, Dlugonski D, Pilutti LA, et al. Psychometric properties of the fatigue severity scale and the modified fatigue impact scale. J. Neurol. Sci. 2013;331(1–2). DOI:10.1016/j.jns.2013.05.023
   PubMed Web of Science ®Google Scholar
• Rosti-Otajärvi E, Hämäläinen P, Wiksten A, et al. Validity and reliability of the fatigue severity scale in Finnish multiple sclerosis patients. Brain Behav. 2017;7(7):e00743. DOI: 10.1002/brb3.743.
   Web of Science ®Google Scholar
• Gavrilov YV, Shkilnyuk GG, Valko PO, et al. Validation of the Russian version of the fatigue impact scale and fatigue severity scale in multiple sclerosis patients. Acta Neurol. Scand. 2018;138(5):408-416. DOI:10.1111/ane.12993.
   PubMed Web of Science ®Google Scholar
• Bakalidou D, Skordilis EK, Giannopoulos S, et al. Validity and reliability of the FSS in Greek MS patients. Springerplus. 2013;2(1). DOI:10.1186/2193-1801-2-304
   PubMedGoogle Scholar
• Lerdal A, Johansson S, Kottorp A, et al. Psychometric properties of the fatigue severity scale: Rasch analyses of responses in a Norwegian and a Swedish MS cohort. Mult Scler. 2010;16(6). DOI:10.1177/1352458510370792
   PubMed Web of Science ®Google Scholar
• Rietberg MB, Van Wegen EEH, Kwakkel G. “Measuring fatigue in patients with multiple sclerosis: reproducibility, responsiveness and concurrent validity of three Dutch self-report questionnaires,”. Disabil Rehabil. 2010;32(22). DOI:10.3109/09638281003734458
   PubMed Web of Science ®Google Scholar
• Ghotbi N, Nakhostin Ansari N, Fetrosi S, et al. Fatigue in Iranian patients with neurological conditions: an assessment with Persian fatigue severity scale. Heal Sci J. 2013.
   Google Scholar
• Fisk JD, Ritvo PG, Ross L, et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin. Infect. Dis. 1994;18. DOI:10.1093/clinids/18.Supplement_1.S79
   PubMed Web of Science ®Google Scholar
• Armutlu K, Keser I, Korkmaz N, et al. Psychometric study of Turkish version of fatigue impact scale in multiple sclerosis patients. J. Neurol. Sci. 2007;255(1–2):64-68. DOI:10.1016/j.jns.2007.01.073.
   PubMed Web of Science ®Google Scholar
• Flensner G, Anna-Christina E, Söderhamn O. Reliability and validity of the Swedish version of the fatigue impact scale (FIS). Scand. J. Occup. Ther. 2005;12(4). DOI:10.1080/11038120510031806
   PubMedGoogle Scholar
• Losonczi E, Bencsik K, Rajda C, et al. Validation of the fatigue impact scale in Hungarian patients with multiple sclerosis. Qual. Life Res. 2011;20(2). DOI:10.1007/s11136-010-9749-7
   PubMed Web of Science ®Google Scholar
• Heidari M, Nabavi SM, Akbarfahim M, et al. Psychometric properties of the Persian version of the fatigue impact scale (FIS-P) in patients with multiple sclerosis. Iran Rehabil J. 2015;13(3):32-38.
   Google Scholar
• Debouverie M, Pittion-Vouyovitch S, Louis S, et al. Validity of a French version of the fatigue impact scale in multiple sclerosis. Mult. Scler. 2007;13(8). DOI:10.1177/1352458507077942
   Web of Science ®Google Scholar
• Meads DM, Doward LC, McKenna SP, et al. The development and validation of the unidimensional fatigue impact scale (U-FIS). Mult. Scler. 2009;15(10). DOI:10.1177/1352458509106714
   Web of Science ®Google Scholar
• Doward LC, Meads DM, Fisk J, et al. International development of the unidimensional fatigue impact scale (U-FIS). Value Heal. 2010;13(4):463-468. DOI:10.1111/j.1524-4733.2010.00706.x.
   Web of Science ®Google Scholar
• Twiss J, Doward LC, McKenna SP, et al. Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS). Health Qual Life Outcomes. 2010;8(1). DOI:10.1186/1477-7525-8-117
   PubMed Web of Science ®Google Scholar
• Mills RJ, Young CA, Pallant JF, et al. Rasch analysis of the modified fatigue impact scale (MFIS) in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2010;81(9). DOI:10.1136/jnnp.2008.151340
   Web of Science ®Google Scholar
• Rooney S, McFadyen DA, Wood DL, et al. Minimally important difference of the fatigue severity scale and modified fatigue impact scale in people with multiple sclerosis. Mult Scler Relat Disord. 2019;35. DOI:10.1016/j.msard.2019.07.028
   PubMed Web of Science ®Google Scholar
• Farran N, Safieddine BR, Bayram M, et al. Factors affecting MS patients’ health-related quality of life and measurement challenges in Lebanon and the MENA region. Mult Scler J - Exp Transl Clin. 2020;6(1):2055217319848467. DOI: 10.1177/2055217319848467.
   PubMedGoogle Scholar
• Alawami AS, Abdulla FA. Psychometric properties of an Arabic translation of the modified fatigue impact scale in patients with multiple sclerosis. Disabil Rehabil. 2020:1-2. DOI:10.1080/09638288.2020.1731853
   PubMed Web of Science ®Google Scholar
• Ghajarzadeh M, Jalilian R, Eskandari G, et al. Validity and reliability of Persian version of modified fatigue impact scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.. Disabil Rehabil. 2013;35(18):1509–12. DOI: 10.3109/09638288.2012
   Google Scholar
• Bakalidou D, Voumvourakis K, Tsourti Z, et al. Validity and reliability of the Greek version of the modified fatigue impact scale in multiple sclerosis patients. Int. J. Rehabil. Res. 2014;37(3). DOI:10.1097/MRR.0000000000000057
   PubMed Web of Science ®Google Scholar
• Kos D, Kerckhofs E, Carrea I, et al. Evaluation of the modified fatigue impact scale in four different European countries. Mult. Scler. 2005;11(1). DOI:10.1191/1352458505ms1117oa
   PubMed Web of Science ®Google Scholar
• Pust GEA,  Pöttgen J, Randerath J, et al. In search of distinct MS-related fatigue subtypes: results from a multi-cohort analysis in 1.403 MS patients. J Neurol. 2019;266(7):1663-1673. DOI:10.1007/s00415-019-09311-2.
   PubMed Web of Science ®Google Scholar
• Pavan K, Schmidt K, Marangoni B, et al. Multiple sclerosis: cross-cultural adaptation and validation of the modified fatigue impact scale. Arq Neuropsiquiatr. 2007;65(3A):669-73. DOI: 10.1590/s0004-282x2007000400024.
   Web of Science ®Google Scholar
• Masuda H, Mori, M., Uzawa, A, et al. Validation of the Japanese version of the modified fatigue impact scale and assessment of the effect of pain on scale responses in patients with multiple sclerosis. Clin Exp Neuroimmunol. 2018;85:64-68. DOI:10.1111/cen3.12236.
   Google Scholar
• Kos D, Nagels G, D’Hooghe MB, et al. A rapid screening tool for fatigue impact in multiple sclerosis. BMC Neurology. 2006;6(1). DOI:10.1186/1471-2377-6-27
   PubMed Web of Science ®Google Scholar
• Zhang Y, Taylor BV, Simpson S, et al. Validation of 0–10 MS symptom scores in the Australian multiple sclerosis longitudinal study. Mult. Scler. Relat. Disord. 2020;39. DOI:10.1016/j.msard.2019.101895
   Web of Science ®Google Scholar
• Fernández O, Fernández V, Baumstarck-Barrau K, et al. Validation of the Spanish version of the multiple sclerosis international quality of life (musiqol) questionnaire. BMC Neurol. 2011;11(1):127. DOI:10.1186/1471-2377-11-127.
   PubMed Web of Science ®Google Scholar
• Baumstarck-Barrau K, Pelletier J, Simeoni MC, et al. French validation of the multiple sclerosis international quality of life questionnaire. Rev Neurol (Paris). 2011;167(6–7). DOI:10.1016/j.neurol.2010.10.008
   PubMed Web of Science ®Google Scholar
• Thumboo J, Seah A, Tan CT, et al. Asian adaptation and validation of an English version of the multiple sclerosis international quality of life questionnaire (MusiQoL). Ann Acad Med Singapore. 2011;40(2):67-73.
   PubMed Web of Science ®Google Scholar
• Ghajarzadeh M, Azizi S, Moghadasi AN, et al. Validity and reliability of the Persian version of the PERception de la scle’rose en plaques et de ses pousse’es questionnaire evaluating multiple sclerosis-related quality of life. Int J Prev Med. 2016;7(1):25. DOI:10.4103/2008-7802.174773.
   Google Scholar
• Baroin A, Chopard G, Siliman G, et al. Validation of a new quality of life scale related to multiple sclerosis and relapses. Qual Life Res. 2013;22(8)1943-1954. DOI:10.1007/s11136-012-0334-0.
   PubMed Web of Science ®Google Scholar
• Schwartz CE, Vollmer T, Lee H. Reliability and validity of two self-report measures of impairment and disability for MS. Neurology. 1999;52(1). DOI:10.1212/WNL.52.1.63
   Web of Science ®Google Scholar
• Schwartz CE, Bode RK, Quaranto BR, et al. “The symptom inventory disability-specific short forms for multiple sclerosis: construct validity, responsiveness, and interpretation,”. Arch Phys Med Rehabil. 2012;93(9):1617-1628.e1. DOi: 10.1016/j.apmr.2012.01.012.
   Web of Science ®Google Scholar
• Kos D, Kerckhofs E, Nagels G, et al. Assessing fatigue in multiple sclerosis: Dutch modified fatigue impact scale. Acta Neurol Belg. 2003;103(4):185-191.
   PubMed Web of Science ®Google Scholar
• Mathiowetz V. Test-retest reliability and convergent validity of the fatigue impact scale for persons with multiple sclerosis. Am. J. Occup. Ther. 2003;57(4). DOI:10.5014/ajot.57.4.389
   Web of Science ®Google Scholar
• Mills RJ, Young CA, Pallant JF, et al. Development of a patient reported outcome scale for fatigue in multiple sclerosis: the neurological fatigue index (NFI-MS). Health Qual Life Outcomes. 2010;8(1). DOI:10.1186/1477-7525-8-22
   PubMed Web of Science ®Google Scholar
• Derksen A, Mokkink LB, Rietberg MB, et al. Validation of a Dutch version of the neurological fatigue index (NFI-MS) for patients with multiple sclerosis in the netherlands. Qual Life Res. 2013;22(9). DOI:10.1007/s11136-013-0375-z
   PubMed Web of Science ®Google Scholar
• Lopes J, Lavado EL, Kaimen-Maciel DR. Validation of the Brazilian version of the neurological fatigue index for multiple sclerosis. Arq Neuropsiquiatr. 2016;74(4). DOI:10.1590/0004-282X20160030
   Web of Science ®Google Scholar
• Penner IK, Raselli C, Stöcklin M, et al. The fatigue scale for motor and cognitive functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult. Scler. 2009;15(12). DOI:10.1177/1352458509348519
   Web of Science ®Google Scholar
• Oervik MS, Sejbaek T, Penner IK, et al. Validation of the fatigue scale for motor and cognitive functions in a Danish multiple sclerosis cohort. Mult Scler Relat Disord. 2017;17. DOI:10.1016/j.msard.2017.07.017
   PubMed Web of Science ®Google Scholar
• Vickrey BG, Hays RD, Harooni R, et al. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995;4(3):187-206. DOI: 10.1007/BF02260859.
   Web of Science ®Google Scholar
• Vickrey BG, Hays RD, Genovese BJ, et al. Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. J. Clin. Epidemiol. 1997;50(5). DOI:10.1016/S0895-4356(97)00001-2
   PubMed Web of Science ®Google Scholar
• Simeoni MC, Auquier P, Fernandez O, et al. Validation of the multiple sclerosis international quality of life questionnaire. Mult. Scler. 2008;14(2):219-230. DOI:10.1177/1352458507080733.
   PubMed Web of Science ®Google Scholar
• Jamroz-Wiśniewska A, Stelmasiak Z, Bartosik-Psujek H. Validation analysis of the Polish version of the multiple sclerosis international quality of life questionnaire (MusiQoL). Neurol Neurochir Pol. 2011;45(3). DOI:10.1016/S0028-3843(14)60076-1
   PubMed Web of Science ®Google Scholar
• Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international delphi study. Qual. Life Res. 2010;19(4):539-549. DOI:10.1007/s11136-010-9606-8.
   PubMed Web of Science ®Google Scholar
• Mokkink LB, Terwee CB, Knol DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: A clarification of its content. BMC Med. Res. Methodol. 2010;10(1):22. DOI:10.1186/1471-2288-10-22.
   Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11). DOI:10.1212/WNL.33.11.1444
   PubMed Web of Science ®Google Scholar